LFH Regulatory
Regulatory experts LFH Regulatory has announced its attendance at MEDICA 2024 taking place November 11-14, to provide invaluable insights and support to healthcare innovators facing the complexities of the UK and EU markets.
The UK-based consultancy, specialising in regulatory, quality, and clinical affairs for medical devices and in vitro diagnostics (IVDs), says it is keen to engage with companies looking to navigate these intricate markets.
Laura Friedl-Hirst, the founder of LFH Regulatory said: “Many companies are bypassing the UK and Europe, opting to go straight to the USA because they perceive it as too complicated. It doesn’t have to be. We look forward to engaging with anyone interested in these markets and helping them navigate and simplify their regulatory pathways.”
Since its establishment in 2019, LFH Regulatory says it has evolved into a team of passionate professionals dedicated to making regulation and compliance as stress-free as possible. In light of recent regulatory changes following Brexit, the consultancy has been instrumental in guiding companies through the increasingly challenging landscape of medical device regulations in the UK.
According to recent reports, it is estimated that over 60% of companies in the medical device sector have expressed concerns about the regulatory complexities in the UK and EU markets.
“The commitment to building strong, long-term relationships with clients sets LFH Regulatory apart,” continued Friedl-Hirst.
“The team believes that collaboration and open communication are essential to understanding the unique challenges and goals of each client. By working closely with businesses and products, LFH Regulatory can provide tailored solutions that alleviate the stress associated with medical device and IVD regulation.”
Throughout the exhibition LFH Regulatory will be located in the UK Pavilion.
